Literature DB >> 19122472

Aqueous humor concentrations of topically administered caspofungin in rabbits.

Christian K Vorwerk1, S Tuchen, F Streit, L Binder, W Hofmüller, W Behrens-Baumann.   

Abstract

BACKGROUND: The echinocandin caspofungin (CAS) is a novel antifungal drug with fungicidal in vitro activity against all Candida spp., which are the most frequent cause of fungal keratitis. Penetration of CAS through the cornea into the aqueous humor after topical administration was investigated.
METHODS: A CAS solution with a concentration of 7 mg/ml was applied onto each rabbit's cornea. Drug application after corneal epithelium abrasion was processed in different time intervals: single application with aqueous humor sampling after 1 and 2 h. In addition, after continuous application of CAS every 30 min, aqueous humor concentrations of CAS after 1, 2 and 5 h were analyzed by liquid-chromatography tandem mass spectrometry.
RESULTS: Topical administration of CAS without corneal epithelium abrasion resulted in no detectable amounts of the drug in the aqueous humor. However, with corneal abrasion, after a single application, levels of 2.16 +/- 1.57 microg/ml (n = 6) were reached after 1 h and then decreased to 1.76 +/- 0.88 microg/ml (n = 2) after 2 h. After serial application every 30 min, the following intracameral levels of CAS were detected: after 1 h, 2.11 +/- 1.09 microg/ml (n = 6); after 2 h, 4.94 +/- 1.80 microg/ml (n = 5), and after 5 h, 3.45 +/- 2.11 microg/ml (n = 6).
CONCLUSION: In the aqueous humor, therapeutic drug levels can be reached that cover the MICs of most fungi after epithelial abrasion. To achieve a sustained high level of CAS as an effective antifungal therapy for corneal keratitis, CAS should be administered topically every 30 min after removal of the corneal epithelium. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19122472     DOI: 10.1159/000187627

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  6 in total

1.  Rapid and sensitive liquid chromatography/mass spectrometry assay for caspofungin in human aqueous humor.

Authors:  Chin Fen Neoh; Hui He; Jian Li; Robert O Fullinfaw; Lok Leung; Anant Misra; Rasik B Vajpayee; Geoffrey E Davies; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2010-07-26       Impact factor: 5.191

2.  Whole-body physiology-based pharmacokinetics of caspofungin for general patients, intensive care unit patients and hepatic insufficiency patients.

Authors:  Qian-Ting Yang; Ya-Jing Zhai; Lu Chen; Tao Zhang; Yan Yan; Ti Meng; Lei-Chao Liu; Li-Mei Chen; Xue Wang; Ya-Lin Dong
Journal:  Acta Pharmacol Sin       Date:  2018-05-31       Impact factor: 6.150

3.  Stability of extemporaneously prepared 0.5-percent caspofungin eye drops: a potential cost-savings exercise.

Authors:  Chin Fen Neoh; Jovan Jacob; Lok Leung; Jian Li; Angela Stathopoulos; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

4.  Penetration of topically administered 0.5-percent caspofungin eye drops into human aqueous humor.

Authors:  Chin Fen Neoh; Lok Leung; Anant Misra; Rasik B Vajpayee; Geoffrey E Davies; Robert O Fullinfaw; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2011-01-24       Impact factor: 5.191

Review 5.  Fungal keratitis: Mechanisms of infection and management strategies.

Authors:  Christopher Donovan; Eduardo Arenas; Ramesh S Ayyala; Curtis E Margo; Edgar M Espana
Journal:  Surv Ophthalmol       Date:  2021-08-20       Impact factor: 6.197

Review 6.  [Keratomycosis: diagnosis and therapy].

Authors:  W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.